{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Bao T"],"funding":["Breast Cancer Now","National Institute for Health Research (NIHR)","NCI NIH HHS"],"pagination":["167-74"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC3594526"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["138(1)"],"pubmed_abstract":["Up to 50 % of women receiving aromatase inhibitor (AI) complain of AI-associated musculoskeletal symptoms (AIMSS) and 15 % discontinue treatment. We conducted a randomized, sham-controlled trial to evaluate whether acupuncture improves AIMSS and to explore potential mechanisms. Postmenopausal women with early stage breast cancer, experiencing AIMSS were randomized to eight weekly real or sham acupuncture sessions. We evaluated changes in the Health Assessment Questionnaire Disability Index (HAQ-DI) and pain visual analog scale (VAS) following the intervention compared to baseline. Serum estradiol, β-endorphin, and proinflammatory cytokine concentrations were measured pre and post-intervention. We enrolled 51 women of whom 47 were evaluable, including 23 randomized to real and 24 to sham ac"],"journal":["Breast cancer research and treatment"],"pubmed_title":["A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors."],"pmcid":["PMC3594526"],"funding_grant_id":["BREAST CANCER NOW RESEARCH CENTRE","R21 CA173263","NF-SI-0512-10122","K12 CA126849","K12 CA126849 A"],"pubmed_authors":["Folkerd E","Jeter S","Giles JT","Tan M","Tarpinian K","Chumsri S","Gould J","Cai L","Bao T","Tkaczuk K","Singh H","Dowsett M","Betts K","Tait N","Medeiros M","Stearns V","Armstrong DK"],"additional_accession":[]},"is_claimable":false,"name":"A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors.","description":"Up to 50 % of women receiving aromatase inhibitor (AI) complain of AI-associated musculoskeletal symptoms (AIMSS) and 15 % discontinue treatment. We conducted a randomized, sham-controlled trial to evaluate whether acupuncture improves AIMSS and to explore potential mechanisms. Postmenopausal women with early stage breast cancer, experiencing AIMSS were randomized to eight weekly real or sham acupuncture sessions. We evaluated changes in the Health Assessment Questionnaire Disability Index (HAQ-DI) and pain visual analog scale (VAS) following the intervention compared to baseline. Serum estradiol, β-endorphin, and proinflammatory cytokine concentrations were measured pre and post-intervention. We enrolled 51 women of whom 47 were evaluable, including 23 randomized to real and 24 to sham ac","dates":{"release":"2013-01-01T00:00:00Z","publication":"2013 Feb","modification":"2025-04-19T09:55:02.536Z","creation":"2019-03-26T22:32:17Z"},"accession":"S-EPMC3594526","cross_references":{"pubmed":["23393007"],"doi":["10.1007/s10549-013-2427-z"]}}